ALT,Altimmune, Inc. | Healthcare

Healthcare

ALT

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Altimmune, Inc.ALT

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases.

The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and non-alcoholic steatohepatitis.

It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus.

The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015.

Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

Latest News >

All aboard the Hyperloop: How your commute could be changing

Jul 19, 2021

Think about the future of transportation, and you might envision the old animated show "The Jetsons," with everyone flying around in personal spaceships. Josh Giegel wants to start from scratch. The chief executive and co-founder of Virgin Hyperloop foresees us zipping between cities in minutes, a future not as far off as you may think.

Ethereum co-founder quitting crypto space as he 'doesn’t feel safe'

Jul 19, 2021

“I don’t feel necessarily safe in this space. If I was focused on larger problems, I think I’d be safer,” said Di Iorio.

Blue Origin sees clear skies for inaugural space flight by Bezos and crewmates

Jul 19, 2021

Billionaire American businessman Jeff Bezos and his three crewmates engaged in a crash course of training on Sunday in preparation for his company Blue Origin's inaugural flight to the edge of space planned for Tuesday. The mission would represent the world's first unpiloted flight to space with an all-civilian crew. Blue Origin, which will have none of its staff astronauts or trained personnel onboard, expressed confidence at a briefing on Sunday.

Tencent to buy British video game company Sumo in $1.3 bn deal

Jul 19, 2021

Chinese tech giant Tencent Holdings will buy video game company Sumo Group in a deal that values the British firm at 919 million pounds (USD 1.27 billion), the companies said on Monday.